Tennessee Oncology

What Tennessee Oncology does

Tennessee Oncology is a private, for-profit community-based cancer care provider founded in 1976 and headquartered in Nashville, Tennessee. It operates 35+ clinic locations across Tennessee and North Georgia, delivering a full-spectrum oncology platform that includes medical oncology, hematology, radiation oncology (including a proton therapy center), gynecologic oncology, imaging, infusion therapy, cellular therapy (including CAR-T), and an early-phase clinical research unit. Supporting services span Park Pharmacy (specialty oncology pharmacy), genetic counseling, integrative oncology, palliative care, psychosocial oncology, survivorship care, and financial counseling.

The practice is affiliated with OneOncology, a national partnership of independent community oncology practices, and houses the McKay Institute for Oncology Transformation and the Greco-Hainsworth Centers for Research as innovation and clinical-research arms. It also holds a minority equity stake in OncoveryCare, with which it has expanded a survivorship-care program to all 35 clinics. The practice has begun deploying third-party AI tools — including ambient clinical-documentation scribes, automated fax processing, and Reimagine Care's "Remi" autonomous care assistant — and was an early adopter of CMS's Medicare digital health record system.

Revenue is generated primarily through fee-for-service billing to Medicare, Medicaid, and private insurance payers for clinical services, supplemented by clinical trial participation, specialty pharmacy revenue, and ancillary services. Patient access flows through physician referrals, insurance networks, and direct self-referral across the regional clinic footprint.

Name

Tennessee Oncology

Legal name

Tennessee Oncology

Website

https://tnoncology.com

Company type

Private

Founded year

1976

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Tennessee Oncology is a private community-based cancer care provider operating 35+ clinics across Tennessee and North Georgia, delivering medical, radiation, and surgical oncology plus infusion, imaging, proton therapy, clinical trials, and survivorship services to cancer patients.

Ownership category

akta.pro rank

Product category

Oncology Care Services

NAICS

Offices of Physicians (62111), Other Outpatient Care Centers (62149)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industries

Radiation Oncology (HLAKAFAC), Gynecologic Oncology (HLAKAFAF), Surgical Oncology (HLAKAFAG), Oncology Specialty Pharmaceuticals (HLAIACAA)

Keywords

• Oncology care services
• Cancer treatment
• Radiation oncology
• Hematology services
• Clinical trials

Headquarters

HQ city

Nashville

HQ country

United States

HQ region

North America

Offices34 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Cancer Care Services: Provides comprehensive cancer care services including medical oncology, hematology, radiation oncology, gynecologic oncology, imaging, and infusion therapy through its network of clinics. Revenue is generated through patient services billed to Medicare, Medicaid, and private insurance payers.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Tennessee Oncology is a community-based cancer care practice that provides comprehensive cancer treatment and supportive services across 35+ clinic locations in Tennessee and North Georgia. Its offerings span medical oncology, hematology, radiation oncology, gynecologic oncology, cellular therapy, proton therapy, infusion therapy, diagnostic imaging, early-phase clinical trials, and ancillary support services such as genetic counseling, palliative care, psychosocial oncology, survivorship care, and on-site specialty pharmacy.

Product overview

Tennessee Oncology operates as a comprehensive, multi-module cancer care platform comprising one of the nation's largest community-based oncology networks with 35+ clinic locations across Tennessee and North Georgia. The platform centers on core cancer treatment services (Medical Oncology, Radiation Oncology, Hematology, Gynecologic Oncology) enhanced by specialized treatment centers including a Proton Therapy Center, Cellular Therapy program, and Drug Development Unit for early-phase clinical trials. The offering is augmented by integrated support services (Park Pharmacy, Genetic Counseling, Integrative Oncology, Palliative Care, Psychosocial Oncology, Survivorship Care, Financial Counseling) and sub-branded specialty centers (Nashville Breast Center, Women's Health Center, The Surgical Clinic, Center for Blood Cancers). Digital patient engagement is facilitated through Noona and Navigating Care patient portals. The platform also includes research institutes (Greco-Hainsworth Centers for Research, McKay Institute for Oncology Transformation) that drive clinical innovation and trial development.

Differentiator

Problem solved

Functional benefit

Brands

• The Surgical Clinic: Surgical services offered within the Tennessee Oncology network
• Nashville Breast Center
• Women's Health Center
• McKay Institute for Oncology Transformation
• Greco-Hainsworth Centers for Research
• Park Pharmacy
• Proton Center

Products and services

• Medical Oncology Drug-based cancer treatment including chemotherapy and immunotherapy delivered by oncologists across the Tennessee Oncology clinic network; serves adult cancer patients.
• Radiation Oncology Radiation therapy services including external beam radiation delivered across multiple radiation oncology centers in Tennessee; serves cancer patients requiring radiotherapy.
• Hematology Specialized treatment for blood cancers and blood disorders including leukemia, lymphoma, and myeloma; serves patients with hematologic malignancies and disorders.
• Gynecologic Oncology Specialized cancer care for women's reproductive cancers, including ovarian, cervical, and uterine cancers, delivered through the Women's Health Center locations.
• Cellular Therapy Advanced cellular-based cancer treatments including CAR-T cell therapy for eligible patients.
• Proton Therapy Specialized proton beam radiation therapy delivered from the Proton Center in Franklin, TN, for precise cancer treatment.
• Infusion Therapy Outpatient infusion services for chemotherapy, immunotherapy, and other intravenous cancer treatments delivered at multiple locations.
• Imaging Services Diagnostic imaging including PET scans and radiology services for cancer diagnosis, staging, and treatment monitoring.
• Clinical Trials / Drug Development Unit Early-phase clinical research unit providing cancer patients access to innovative therapies and investigational cancer treatments through clinical trials.
• Park Pharmacy (Specialty Pharmacy) On-site specialty pharmacy providing prescription assistance and medication management services for cancer patients, staffed by dedicated pharmacists.
• Survivorship Care

Quantifiable outcome

• Expanded survivorship care services to all solid tumor survivors across 35 clinic network

Named customers2 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

Five partnerships are on record, tiered core and minor.

• OncoveryCarecoreStrategic or Co-development Partner · 17 February 2026Tennessee Oncology and OncoveryCare expanded their partnership to offer survivorship care to all solid tumor survivors across Tennessee Oncology's network of 35 clinics in Tennessee and North Georgia. The expansion builds on a 2024 partnership that generated thousands of patient visits, addressing the growing US cancer survivor population projected to double to 22 million by 2030. Tennessee Oncology's McKay Institute for Oncology Transformation previously participated in OncoveryCare's seed financing in 2024.
• Sarah Cannon Research InstitutecoreStrategic or Co-development PartnerSarah Cannon Research Institute is referenced as a key collaborator in lung cancer research and treatment, with Dr. David Spigel highlighted as a speaker at Lung Cancer Research Foundation events.
• OneOncologycoreStrategic or Co-development PartnerTennessee Oncology is affiliated with OneOncology, a partnership of independent community oncology practices focused on advancing cancer care through clinical innovation and practice excellence.
• The Surgical ClinicminorChannel Partner/ Reseller/ DistributorThe Surgical Clinic operates multiple locations within Tennessee Oncology's network, providing surgical oncology services as part of integrated cancer care delivery.
• CMS (Centers for Medicare & Medicaid Services)coreStrategic or Co-development PartnerTennessee Oncology is one of three early-adopter practices for Medicare's digital health record system, working with CMS to enable Medicare enrollees to export and share their medical records through a mobile app with QR code functionality.

Scale indicators4 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Florida Cancer Specialists & Research Institute: One of the largest independent, community-based oncology practices in the U.S., offering medical oncology, hematology, radiation oncology, and clinical trials across a multi-state footprint. Highly comparable to Tennessee Oncology in scale, specialty breadth, and community-based delivery model.
• OneOncology: Partnership platform of independent community oncology practices of which Tennessee Oncology is an affiliate. Provides technology, payer contracting, and practice management services — both a strategic ally and a structural benchmark for peer practice performance.
• Sarah Cannon Research Institute: Cancer research and clinical trials organization referenced as a key collaborator in Tennessee Oncology's lung cancer research and treatment. Operates early-phase clinical research units at community oncology sites comparable to Tennessee Oncology's Drug Development Unit.
• Highlands Oncology Group: Community-based multi-specialty oncology practice referenced alongside Tennessee Oncology as a Canopy AI phone-operator deployment site. Comparable in community-based, AI-forward, multi-site oncology delivery.
• Compass Oncology: Independent community oncology practice operating across multiple sites in Oregon and Washington. Comparable in physician-led, multi-clinic community oncology delivery model with integrated imaging, infusion, and clinical trials.
• New York Cancer & Blood Specialists: Large independent community oncology practice in the Northeast offering medical oncology, hematology, radiation oncology, and clinical trials. Similar in scale and multi-specialty community delivery to Tennessee Oncology.

Broad incumbents

• The US Oncology Network (McKesson): The largest network of community-based oncology practices in the U.S., now part of McKesson. Tennessee Oncology's affiliation with OneOncology (itself a community oncology partnership) places it in the same competitive orbit, with overlapping payer negotiations and clinical trial access.
• Vanderbilt-Ingram Cancer Center: NCI-designated academic cancer center located in Nashville, Tennessee. Represents the most direct academic-medical-center competitor for complex oncology cases in Tennessee Oncology's home market.

Others

• Reimagine Care: AI-enabled care platform whose autonomous AI assistant Remi is deployed across partner community oncology practices including Tennessee Oncology. An enabling technology partner rather than a direct competitor, but its adoption trajectory will shape Tennessee Oncology's competitive positioning on patient experience and ED avoidance.
• Canopy (Canopy Health): AI phone operator ('Kathy') that handles incoming calls at community oncology practices including Tennessee Oncology peers. Enabling technology vendor that improves operational efficiency for community oncology; relevant for benchmarking Tennessee Oncology's tech adoption curve.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/tnoncology
• Facebookfacebook.com/tennesseeoncology
• LinkedInlinkedin.com/company/tennessee-oncology
• Instagraminstagram.com/tnoncology

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tennessee Oncology